Clinical trial
High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of…
NCT00003623 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003623 |
|---|---|
| Title | High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer |
| Official title | Megadose Vitamins as Chemoprevention of Transitional Cell Carcinoma of the Bladder |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Dietary Supplement, Other |
| Interventions | multivitamin, Placebo |
| Enrollment | 21 |
| Start date | Oct 1, 1999 |
| Primary completion | Mar 1, 2003 |
| Completion | Mar 1, 2003 |
| First posted | Feb 20, 2004 |
| Last update posted | Jul 13, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: